Come up with a name for your new list and we'll add to it:
Tarsius Pharma raised a round of funding on September 10, 2018. Investors include
Sun Pharmaceutical Industries.
Tarsius is ab early-stage research and development company focusing on the development of drug candidates in the ophthalmology segment.…